rheumatoid
arthriti
ra
chronic
symmetr
autoimmun
diseas
character
synovi
inflamm
prolifer
accompani
cartilag
eros
bone
loss
onethird
patient
eventu
experi
employ
disabl
lower
qualiti
life
diseas
larg
respons
high
socioeconom
burden
ra
furthermor
mortal
rate
ra
patient
higher
healthi
popul
aim
ra
treatment
achiev
remiss
mani
ra
patient
judg
consult
rheumatologist
remiss
receiv
convent
therapi
still
show
structur
deterior
therefor
longterm
goal
treatment
prevent
joint
destruct
comorbid
diseas
number
report
suggest
modern
therapi
inhibit
joint
damag
satisfactorili
despit
achiev
clinic
remiss
therefor
develop
effect
agent
inhibit
bone
eros
ra
patient
urgent
canon
wnt
signal
pathway
promot
bone
format
stimul
differenti
osteoblast
increas
growth
rate
osteoblast
reduc
apoptosi
also
inhibit
osteoclastogenesi
canon
wnt
signal
pathway
trigger
associ
secretori
wnt
frizzl
fz
receptor
low
densiti
lipoprotein
receptorrel
protein
cell
surfac
stabil
eventu
transloc
nucleu
activ
tcflefmedi
transcript
target
gene
elicit
varieti
effect
includ
induct
osteoblast
differenti
prolifer
solubl
natur
inhibitor
canon
wnt
signal
pathway
may
play
activ
role
inhibit
osteogenesi
bind
ligand
wnt
protein
addit
also
found
bind
kremen
anoth
cell
surfac
coreceptor
form
ternari
complex
rapidli
endocytos
result
deplet
cell
surfac
studi
demonstr
level
serum
significantli
higher
ra
patient
correl
sever
diseas
mous
model
ra
treatment
antibodi
attenu
bone
eros
therefor
may
promis
therapeut
target
ra
bone
loss
last
year
great
progress
made
develop
dna
vaccin
dna
vaccin
mani
advantag
convent
chemic
agent
biolog
agent
protein
vaccin
treatment
diseas
first
plasmid
prepar
rapid
cost
effect
suffer
problem
improp
protein
fold
plasmid
dna
highli
stabl
flexibl
allow
modif
plasmid
sequenc
addit
antigen
present
cell
apc
process
present
epitop
antigen
mhc
ii
molecul
therebi
induc
humor
immun
cellular
immun
activ
immunotherapi
feasibl
revers
disord
autoimmun
diseas
dna
vaccin
proven
effect
anim
model
includ
ra
crohn
diseas
system
erythematosu
lupu
sle
infecti
diseas
extens
evalu
human
advanc
bioinform
softwar
molecular
immunolog
promot
develop
dna
vaccin
current
phase
phase
ii
phase
iii
clinic
trial
identifi
studi
select
panel
twelv
peptid
use
softwar
dnastar
screen
high
affin
immunogen
epitop
vitro
vivo
assay
optim
four
b
cell
epitop
design
novel
multiepitop
dna
vaccin
determin
immunogen
evalu
protect
effect
data
demonstr
dna
vaccin
amelior
bone
eros
significantli
mice
collageninduc
arthriti
cia
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
humidifi
incub
sixweekold
femal
balbc
mice
male
mice
ciasuscept
mous
strain
purchas
hfk
biotechnolog
co
ltd
mice
maintain
specif
pathogenfre
environ
anim
experi
perform
accord
guidelin
anim
care
use
committe
capit
medic
univers
b
cell
epitop
amino
acid
sequenc
human
analyz
use
softwar
dnastar
separ
epitop
synthesi
invitrogen
life
technolog
california
usa
subsequ
indirect
elisa
util
detect
affin
separ
epitop
simpli
plate
coat
peptid
overnight
polyclon
antibodi
dilut
r
system
minneapoli
mn
usa
ad
well
incub
overnight
wash
hrp
conjug
goat
antihuman
secondari
antibodi
dilut
southern
biotech
birmingham
al
usa
ad
plate
incub
h
peptid
immun
balbc
mice
immunogen
measur
previous
describ
reaction
stop
addit
stop
solut
r
system
read
measur
elisa
plate
reader
reduc
bioactiv
vaccin
peptid
intraperiton
appli
week
tibia
collect
acid
phosphatas
kit
sigmaaldrich
st
loui
mo
usa
use
demonstr
osteoclast
four
fragment
sequenc
high
affin
immunogen
select
construct
multiepitop
dna
vaccin
dna
sequenc
encod
four
amino
acid
mutat
glutam
reduc
biolog
activ
aay
spacer
two
adjac
epitop
fragment
use
link
four
select
epitop
cell
epitop
ad
sequenc
termini
final
signal
peptid
human
ad
nterminu
sequenc
synthet
nucleotid
sequenc
name
dp
incorpor
express
vector
use
standard
dna
recombin
procedur
result
recombin
plasmid
pcmvdp
plasmid
immun
extract
purifi
transform
escherichia
coli
strain
use
endotoxinfre
plasmid
extract
kit
roch
mannheim
germani
accord
manufactur
instruct
purifi
plasmid
adjust
concentr
mgml
steril
salin
store
cell
cultur
tissu
cultur
plate
cell
reach
approxim
confluenc
cell
transfect
purifi
plasmid
dna
use
turbofect
vitro
transfect
reagent
fermenta
thermoscientif
pittsburgh
pa
usa
accord
manufactur
instruct
briefli
plasmid
dna
mgml
dilut
serumfre
dmem
turbofect
reagent
ad
dilut
dna
immedi
mix
incub
min
room
temperatur
mixtur
distribut
dropwis
cultur
cell
plate
transfect
cell
cultur
h
cell
lysat
cultur
supernat
collect
analys
protein
cell
lysat
separ
sdspage
gel
transfer
onto
nitrocellulos
membran
electroblot
membran
block
nonfat
dri
milk
tbst
tb
h
room
temperatur
incub
polyclon
rabbit
antibodi
millipor
tbst
contain
bovin
serum
albumin
overnight
wash
three
time
tbst
membran
incub
horseradish
peroxidas
hrp
conjug
goat
antirabbit
igg
proteintech
group
chicago
usa
h
room
temperatur
wash
three
time
membran
expos
supersign
west
pico
stabl
peroxid
solut
pierc
thermoscientif
pittsburgh
pa
usa
protein
secret
cell
cultur
supernat
detect
elisa
briefli
plate
coat
goat
antihuman
antibodi
ngml
r
system
minneapoli
mn
usa
overnight
cell
cultur
supernat
ad
well
incub
overnight
incub
goat
antihuman
antibodi
ngml
r
system
h
work
dilut
streptavidinhrp
ad
well
color
develop
addit
substrat
solut
orthophenylen
diamin
opd
min
reaction
stop
addit
absorb
read
nm
micropl
reader
thermomax
technolog
balbc
mice
inject
intramuscularli
plasmid
pcmvdp
empti
vector
pcmv
seven
day
later
inject
muscl
surgic
remov
frozen
section
prepar
section
dri
min
room
temperatur
fix
anhydr
aceton
incub
min
quench
endogen
peroxidas
block
hors
serum
section
incub
goat
antihuman
antibodi
r
system
overnight
next
day
section
incub
hrpconjug
donkey
antigoat
igg
proteintech
group
h
room
temperatur
posit
signal
detect
diaminobenzidin
dab
r
system
dna
immun
experi
femal
balbc
mice
n
inject
intramuscularli
im
plasmid
pcmvdp
three
time
week
mice
n
immun
empti
vector
pcmv
serv
neg
control
intramuscular
inject
plasmid
dna
follow
electropor
dna
ep
perform
previous
describ
briefli
plasmid
pcmvdp
inject
intramuscularli
one
tibiali
anterior
muscl
use
needl
immedi
inject
electropor
electr
puls
appli
pair
silver
electrod
space
mm
apart
cover
im
inject
site
electr
puls
ms
durat
apart
voltag
v
ie
vcm
first
inject
mous
serum
sampl
collect
interv
store
antibodi
human
evalu
use
elisa
briefli
microtit
plate
coat
recombin
human
protein
ngml
r
system
incub
overnight
wash
three
time
pbst
pb
plate
block
bovin
serum
albumin
bsa
pbst
h
wash
dilut
serum
ad
well
plate
incub
h
wash
five
time
pbst
hrpconjug
goat
antimous
igg
secondari
antibodi
proteintech
group
ad
well
follow
incub
h
next
plate
wash
five
time
pbst
ad
substrat
solut
stop
solut
absorb
read
nm
micropl
reader
thermomax
technolog
endpoint
titer
antibodi
determin
way
serum
sampl
serial
dilut
mice
n
immun
plasmid
pcmvdp
three
time
interv
describ
control
mice
n
immun
equal
amount
empti
vector
pcmv
one
week
final
immun
mice
inject
intraderm
base
tail
bovin
c
ii
emulsifi
complet
freud
adjuv
cfa
contain
mgml
heatkil
mycobacterium
tuberculosi
day
anim
given
booster
inject
bovin
c
ii
dissolv
incomplet
freud
adjuv
ifa
anim
observ
record
everi
day
diseas
onset
clinic
score
assign
evalu
diseas
sever
follow
sign
arthriti
swell
andor
red
one
paw
one
digit
two
joint
involv
three
joint
involv
sever
arthriti
entir
paw
digit
limb
grade
independ
result
maxim
clinic
score
per
affect
anim
determin
protect
effect
dna
vaccin
day
challeng
bovin
c
ii
system
aloka
latheta
laboratori
japan
employ
detect
bone
miner
densiti
bmd
degre
bone
eros
mice
anaesthet
chloral
hydrat
xray
imag
analyz
reconstruct
quantit
analys
use
softwar
vgstudio
max
murin
hind
paw
remov
postmortem
store
neutral
formalin
decalcifi
ethylenediaminetetraacet
acid
edta
week
dehydr
embed
paraffin
section
cut
along
longitudin
axi
stain
toluidin
blue
tb
previous
describ
data
analyz
use
softwar
spss
version
present
mean
sem
differ
two
group
mice
compar
use
student
ttest
p
valu
less
consid
statist
signific
accord
analysi
potenti
b
cell
epitop
human
epitop
predict
softwar
dnastar
panel
twelv
peptid
fragment
synthes
figur
addit
select
high
affin
immunogen
synthesi
peptid
titer
peptid
determin
peptid
greyblu
column
candid
design
dna
vaccin
figur
b
c
furthermor
decreas
patholog
function
peptid
osteoclastform
assay
perform
compar
control
signific
osteoclastogenesi
observ
peptidestreat
group
figur
synthet
nucleotid
sequenc
mute
four
amino
acid
encod
dna
vaccin
clone
eukaryot
express
vector
figur
express
multiepitop
dna
vaccin
vitro
evalu
cell
elisa
show
multiepitop
dna
vaccin
recombin
protein
secret
abundantli
recogn
polyclon
antibodi
figur
addit
western
blot
also
show
cell
transfect
plasmid
pcmvdp
highli
express
recombin
protein
figur
b
assess
express
target
protein
vivo
inject
muscl
mice
stain
antibodi
express
recombin
protein
dna
vaccin
much
higher
muscl
inject
site
control
group
figur
c
due
observ
conclud
multiepitop
gene
express
eukaryot
vitro
vivo
specif
antihuman
antibodi
identifi
balbc
mice
immun
plasmid
pcmvdp
serum
igg
titer
began
increas
earli
week
primari
immun
reach
peak
week
figur
endpoint
titer
specif
antibodi
also
determin
evalu
neutral
effect
vitro
figur
e
although
endpoint
titer
specif
antibodi
exist
persist
serum
month
immun
mice
inject
bovin
c
ii
twice
interv
immun
sign
arthriti
appear
around
day
inject
bovin
c
ii
continu
develop
later
time
point
diseas
incid
prevaccin
mice
posit
control
mice
day
paw
erythema
swell
also
becam
sever
time
control
mice
vaccin
group
figur
b
addit
infiltr
inflammatori
cell
reduc
vaccineimmun
mice
compar
control
figur
c
evalu
amelior
arthrit
bone
joint
structur
well
conserv
vaccin
mice
compar
posit
control
mice
demonstr
microcomput
tomographi
ct
scan
figur
total
bone
miner
densiti
bmd
mice
vaccin
group
significantli
higher
posit
control
group
figur
e
result
tb
stain
show
degre
overal
destruct
cartilag
reduc
markedli
arthrit
paw
vaccin
mice
compar
posit
control
figur
f
result
microct
scan
tb
stain
demonstr
dna
vaccin
attenu
bone
eros
cia
mice
produc
specif
antibodi
b
cell
epitop
first
choic
construct
dna
vaccin
increas
titer
specif
antibodi
combin
predict
softwar
dnastar
affin
immunogen
assay
reduc
potenti
bone
resorpt
natur
synthesi
epitop
inject
balbc
signific
osteoclastogenesi
observ
data
demonstr
separ
epitop
safe
vaccin
util
vivo
increas
immunogen
dna
vaccin
express
host
key
bind
site
kremen
mutat
time
mutat
protein
express
vivo
enhanc
immunogen
vaccin
facilit
epitop
process
four
select
epitop
separ
one
anoth
aay
spacer
aay
express
insid
select
epitop
easili
recogn
proteasom
fulllength
protein
easili
process
present
vivo
express
natur
bodi
increas
immunogen
recombin
dna
vaccin
pan
dr
helper
epitop
padr
ad
enhanc
antibodi
respons
final
signal
peptid
human
ad
nterminu
dna
vaccin
facilit
extracellular
secret
protein
antigen
dna
vaccin
deliveri
method
one
import
factor
affect
immun
effici
method
dna
vaccin
deliveri
current
use
includ
intramuscular
intraperiton
intraven
intraderm
subcutan
inject
other
deliveri
method
plasmid
directli
affect
uptak
gene
affect
express
target
protein
intramuscular
inject
earliest
simplest
method
dna
deliveri
howev
major
administ
plasmid
dna
block
perimysia
skelet
muscl
dna
degrad
dnase
plasma
less
dna
actual
enter
nucleu
recent
electropor
use
dna
vaccin
deliveri
proven
better
dna
deliveri
method
studi
intramuscular
inject
plasmid
dna
follow
electropor
dna
ep
employ
dc
electr
current
disrupt
cell
membran
short
time
allow
plasmid
dna
cross
membran
nucleu
addit
electr
current
caus
cell
destruct
local
inflammatori
reaction
larg
number
inflammatori
cell
includ
macrophag
antigenpres
cell
infiltr
inject
muscl
enhanc
effici
antigen
present
studi
highli
specif
igg
antibodi
serum
induc
earli
week
also
demonstr
effici
electropor
dna
vaccin
neg
regul
canon
wnt
signal
pathway
play
import
role
ra
bone
destruct
inhibit
biolog
function
attenu
bone
destruct
ra
result
show
recombin
human
multiepitop
dna
vaccin
induc
specif
antibodi
effect
neutral
biolog
activ
attenu
bone
destruct
cia
mice
studi
may
provid
potenti
therapi
ra
bone
loss
diseas
